MAR 23, 2016 7:29 AM PDT

Potential New Drug for Treatment of Mesothelioma

WRITTEN BY: Xuan Pham
Asbestos fibersMany people have heard of mesotheliomas through frightening television commercials. But little is known about treatment for this cancer, which happens to be one of the most aggressive and lethal of all cancer types. Now, researchers at the University of Bradford in the UK recently published findings on a drug that could possibly be the first to work against mesothelioma cancer cells. The promising results offer hope to mesothelioma patients who have little to no recourse after diagnosis.
 
As one of the most aggressive cancer types, mesothelioma is a cancer of the lining of the lung. Uniquely, this cancer is caused by exposure to manmade products containing the carcinogen asbestos. When breathed into the lungs, asbestos fibers get trapped and cause scarring and inflammation, triggering serious health conditions like mesothelioma. Though rare nowadays in the US, cases of mesotheliomas are still rampant in other parts of the world due to unregulated use of materials containing asbestos. The disease has a poor prognosis, with less than one-year survival rates after diagnosis.
 
The newly identified drug is known as HRX9, and it works by forcing cancer cells to undergo programmed cell death, or apoptosis. Normal cells divide, grow, and die at regularly scheduled time points; however, cancer cells like that in mesothelioma are resistant to signals for cell death.
 
"Both the immune system and nearby healthy cells send signals instructing damaged and unhealthy cells to undergo apoptosis, which is like programmed 'cell suicide'. But cancer cells have developed a wide range of strategies to ignore these instructions," said Richard Morgan, professor at the University of Bradford's Institute of Cancer Therapeutics, and lead author of the study. Consequently, cancer cells multiple and grow out of control, leading to disease and health complications.
 
HRX9 targets the HOX gene family, which are involved in cell division. In treatment of HRX9 to mice with human mesothelioma tumors, researchers noticed a dramatic decrease in cancer growth. They also found HRX9 resulted in disintegration of tumor blood vessels, which promoted widespread cancer cell deaths.
 
"We've effectively knocked out a key defence mechanism in this cancer through targeting the HOX genes," said Morgan.
 
Further research between mesothelioma and the HOX gene pathway revealed another finding of great interest. Mesothelioma was greatly associated with HOXB4, a member of the HOX gene family. "We examined the amount of HOXB4 protein in tumours of 21 mesothelioma patients and compared it with their length of survival. There was a clear link: the more HOXB4 we found, the shorter time the patient survived, so we may also have found a way to predict which patients have the most aggressive form of this cancer," said Morgan.
 
The study results are preliminary, but quite promising for mesothelioma patients. Further investigations should include data on the long-term effects of HRX9 in the mouse, and whether the decrease in tumor growths can be sustained over a long period of time. 
 

Additional source: EurekAlert!
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
APR 27, 2021
Cardiology
New miRNAs Might Help Diagnose Severe Dilated Cardiomyopathy
APR 27, 2021
New miRNAs Might Help Diagnose Severe Dilated Cardiomyopathy
The heart is one of the most reliable parts of the body. It pumps day and night, delivering fresh oxygen and nutrients t ...
MAY 04, 2021
Cardiology
Does Sleep Apnea Affect Blood Pressure During REM Sleep?
MAY 04, 2021
Does Sleep Apnea Affect Blood Pressure During REM Sleep?
Sleep is a time for your body to rest and recover from the day. Your heart slows down, and your breathing relaxes.   ...
JUN 10, 2021
Clinical & Molecular DX
Algorithm Flags High Risk of Pancreatic Cancer
JUN 10, 2021
Algorithm Flags High Risk of Pancreatic Cancer
In 2021, over 60,000 individuals in the U.S. alone will be diagnosed with pancreatic cancer. Researchers are turning to ...
JUN 17, 2021
Clinical & Molecular DX
A RADICA Approach to Viral Diagnostics
JUN 17, 2021
A RADICA Approach to Viral Diagnostics
  The COVID-19 pandemic has spurred a wave of new technologies for rapid viral diagnostics, given just how critical ...
JUN 29, 2021
Immunology
Speed Up qPCR Sample Preparation for SARS-CoV-2 Detection
JUN 29, 2021
Speed Up qPCR Sample Preparation for SARS-CoV-2 Detection
Amid the widespread outbreak of the COVID-19 caused by SARS-CoV-2, the development of test methods that can efficiently ...
AUG 23, 2021
Clinical & Molecular DX
Better Health Monitoring Protects Nursing Home Residents
AUG 23, 2021
Better Health Monitoring Protects Nursing Home Residents
Residents of nursing homes are particularly susceptible to health complications. Around half of all individuals residing ...
Loading Comments...